Partial Knee Replacement for Osteoarthritis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two types of partial knee replacements for individuals with severe knee arthritis. It compares a knee replacement attached with bone cement to one that does not use cement. The goal is to determine if the cementless option performs as well as the cemented one. Candidates may qualify if they have severe osteoarthritis in the knee, require surgery for pain relief or improved knee function, and have not undergone a knee replacement or significant knee surgery before.
As an unphased trial, this study provides an opportunity to contribute to advancements in knee replacement options and potentially benefit from innovative treatment.
Do I need to stop taking my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, if you are taking immunosuppressive drugs or have received steroid treatments recently, you may not be eligible to participate.
What prior data suggests that the Engage Partial Knee System is safe for osteoarthritis?
Research has shown that both cemented and cementless Engage Partial Knee systems are safe. Studies have found that cemented knee replacements usually have few complications and often improve knee function, performing well over the long term. Most patients experience positive outcomes with them.
Cementless knee systems have also demonstrated good results. Research suggests these systems might have a lower chance of requiring another surgery after ten years compared to cemented ones, indicating their safety and effectiveness.
Both types of knee systems are considered safe in the short term, with no major differences between them.12345Why are researchers excited about this trial?
Researchers are excited about the Engage Partial Knee treatments because they offer two innovative approaches for knee replacement in osteoarthritis patients. The Cemented Engage Partial Knee uses bone cement for secure fixation, potentially offering enhanced stability and longevity compared to traditional methods. On the other hand, the Cementless Engage Partial Knee provides a cutting-edge option that eliminates the need for cement, allowing for natural bone growth and integration, which could lead to quicker recovery times and fewer complications. These advancements could significantly improve outcomes for patients suffering from knee osteoarthritis.
What evidence suggests that this trial's treatments could be effective for osteoarthritis?
This trial will compare two treatment options for knee osteoarthritis: the Cemented Engage Partial Knee and the Cementless Engage Partial Knee. Research has shown that both systems are promising. Participants in the cemented arm may experience a 97% chance of the replacement lasting 10 years without needing replacement. Meanwhile, studies indicate that participants in the cementless arm have a 24% lower chance of needing another surgery compared to those in the cemented arm. Both types help people move and perform daily activities well over the long term. Overall, both treatments appear effective for managing knee osteoarthritis.14678
Who Is on the Research Team?
David A Crawford, MD
Principal Investigator
JIS Research Institute
Are You a Good Fit for This Trial?
This trial is for adults over 21 with severe knee osteoarthritis or avascular necrosis limited to one part of the knee, who haven't found relief through other treatments and have a BMI under 40. They must be able to follow post-op care and return for check-ups. Excluded are those with certain diseases, previous knee surgeries that failed, allergies to metal or cement, pregnant women, drug abusers, heavy smokers, or anyone unlikely to complete the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo unicompartmental knee arthroplasty with either cemented or cementless fixation
Follow-up
Participants are monitored for safety and effectiveness after treatment, including pain score, implant survivorship, range of motion, and KOOS JR score
What Are the Treatments Tested in This Trial?
Interventions
- Engage Partial Knee
Find a Clinic Near You
Who Is Running the Clinical Trial?
JIS Research Institute
Lead Sponsor
Smith & Nephew, Inc.
Industry Sponsor
Dr. Maria Berkman
Smith & Nephew, Inc.
Chief Medical Officer since 2023
MD from Harvard Medical School
Dr. Deepak Nath
Smith & Nephew, Inc.
Chief Executive Officer since 2022
PhD in Theoretical Mechanics, University of California, Berkeley